LB
Life Biosciences LLC
SEC filingOther · Boston, MA
Amount raised$31Msold at filing
Total offering$31M
Investors in the raise8count reported to the SEC
FiledApr 24, 2026first sale Nov 25, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Stuart GibsonDirector
Gerald McLaughlinExecutive Officer, Director
David GuyerDirector
David SinclairDirector
Sharon Rosenzweig-LipsonExecutive Officer
Michael RingelExecutive Officer
Amit ShashankExecutive Officer
Ilan SternDirector
Executive officers, directors and promoters as listed on the Form D.